ARXX THERAPEUTICS AS

0349 OSLO

Finances

Share Ownership

Return on Equity

−144 370,49 %

Current Ratio

2,12

Debt-to-Equity Ratio

313,64

Key figures (NOK)	2022	2021	2020	2019
Revenue	15 056 000	10 845 000	3 244 000	716 000
Net Income	−88 066 000	−33 273 000	−13 581 000	−4 273 000
Total Assets	35 984 000	98 691 000	15 515 000	3 320 000
Total Equity	61 000	88 127 000	11 395 000	2 976 000

Income (NOK)	2022	2021	2020	2019
Revenue	15 056 000	10 845 000	3 244 000	716 000
Expenditure	102 763 000	44 337 000	16 760 000	4 930 000
Operating Profit	−87 708 000	−33 492 000	−13 516 000	−4 214 000
Financial Income	1 639 000	889 000	77 000	6 000
Financial Costs	1 997 000	670 000	142 000	65 000
Financial Balance	−358 000	219 000	−65 000	−59 000
Earnings Before Tax	−88 066 000	−33 273 000	−13 581 000	−4 273 000
Tax	0	0	0	0
Net Income	−88 066 000	−33 273 000	−13 581 000	−4 273 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	398 000	603 000	133 000	133 000
Total Current Assets	35 585 000	98 088 000	15 382 000	3 187 000
Total Assets	35 984 000	98 691 000	15 515 000	3 320 000
Total Retained Equity	−139 345 000	−51 278 000	−18 005 000	−4 424 000
Total Equity	61 000	88 127 000	11 395 000	2 976 000
Total Long-Term Debt	19 132 000	0	0	0
Total Current Debt	16 790 000	10 563 000	4 120 000	344 000
Total Equity and Debt	35 984 000	98 691 000	15 515 000	3 320 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	175 000	0	0	0
Other Income	14 881 000	10 845 000	3 244 000	716 000
Revenue	15 056 000	10 845 000	3 244 000	716 000
Cost of Goods Sold	0	0	0	0
Salary Costs	9 857 000	6 914 000	4 527 000	367 000
Depreciation	224 000	184 000	0	0
Impairment	0	0	0	0
Expenditure	102 763 000	44 337 000	16 760 000	4 930 000
Operating Profit	−87 708 000	−33 492 000	−13 516 000	−4 214 000
Financial Income	1 639 000	889 000	77 000	6 000
Financial Costs	1 997 000	670 000	142 000	65 000
Financial Balance	−358 000	219 000	−65 000	−59 000
Dividends	0	0	0	0
Net Income	−88 066 000	−33 273 000	−13 581 000	−4 273 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	265 000	470 000	0	0
Total Tangible Assets	265 000	470 000	0	0
Total Fiancial Fixed Assets	133 000	133 000	133 000	133 000
Total Fixed Assets	398 000	603 000	133 000	133 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	22 302 000	90 207 000	10 694 000	3 072 000
Total Current Assets	35 585 000	98 088 000	15 382 000	3 187 000
Total Assets	35 984 000	98 691 000	15 515 000	3 320 000
Total Equity	61 000	88 127 000	11 395 000	2 976 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	19 132 000	0	0	0
Creditors	15 311 000	5 362 000	1 717 000	198 000
Unpaid Taxes	531 000	275 000	223 000	96 000
Dividends	0	0	0	0
Other Current Debt	948 000	4 927 000	2 180 000	50 000
Total Current Debt	16 790 000	10 563 000	4 120 000	344 000
Total Equity and Debt	35 984 000	98 691 000	15 515 000	3 320 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−144 370,49 %	−37,76 %	−119,18 %	−143,58 %
Debt-to-Equity Ratio	313,64	0	0	0
Operating Profit Margin	−582,55 %	−308,82 %	−416,65 %	−588,55 %
Current Ratio	2,12	9,29	3,73	9,26
Quick Ratio	2,12	9,29	3,73	9,26
Equity Ratio	0	0,89	0,73	0,9
Gross Profit Margin	100 %	100 %	100 %	100 %